Could buprenorphine patients prefer community pharmacy?


World-first research shows how community pharmacy depot buprenorphine services may help patients feel less stigmatised People who receive depot buprenorphine in community pharmacies have highlighted “hostile” and “judgemental” interactions when getting their injections in previous settings. Joel Hillman and Rebekah Moles from the Faculty of Medicine and Health, University of Sydney, presented their research into

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Work stress a factor in convicted pharmacist’s drinking
Next Research Roundup